1.Indwelling Catheter and Urinary Infection:Monitoring Analysis and Nursing
Chinese Journal of Nosocomiology 2009;0(13):-
OBJECTIVE To find out risk factors of urinary infection caused by indwelling catheter. METHODS The data of indwelling catheter patients were recorded according to the pre-planned table by adopting survey techniques of prefigure and analyzed retrospectively. The infection cases were diagnosed by rule of Diagnostic Standard of Hospital Infection issued by Ministry of Health. RESULTS A total of 734 indwelling catheter patients were surveyed from Jan to Dec in 2006. Of the 100 patients,the infection rate was 13.62%. The main reasons were the duration of indwelling catheter and improper usage of antibiotics. The main pathogeny was G-bacteria,of which Escherichia coli accounted for 28.95%,fungi for 31.58%. CONCLUSIONS Enhancing nursing care for indwelling catheter patients; reducing the duration of indwelling as soon as possible and using antibaotics properly according to germiculture and sensibility.
2.The research of different diet modes of patients with hemoptysis of pulmonary tuberculosis after embolism operation
Chuang TAN ; Sheng LEI ; Hui TANG ; Yanhua ZENG
Chinese Journal of Practical Nursing 2017;33(11):815-818
Objective To discuss the influences of fasting on the embolism adverse reactions, sense of hunger, blood amylase, blood glucose and anxiety of patients with hemoptysis of pulmonary tuberculosis after embolism operation. Methods Selected 92 cases of patients with hemoptysis of pulmonary tuberculosis who have taken bronchial artery embolism in Pulmonary hospital of Changsha central hospital from June 2014 to December 2015,randomly divided the patients into three groups according to operating date, namely, the non-fasting group, 6h fasting group and 24h fasting group. The non-fasting group have routine diet after the operation; the 6h fasting group and 24h fasting group respectively fasted for 6 hours and 24 hours. Then compared the embolism adverse reactions, sense of hunger, blood amylase, blood glucose and anxiety of the patients in the three groups so as to check whether there is difference. Results Before operation, there was not significant difference in adverse reaction of embolism, sense of hunger, anxiety, blood glucose and amylase between the three groups (P > 0.05). After operation, there was significant difference in hunger sense of difference between the three groups(F=13.308,P<0.05), the hunger sense of 24 h fasting group was more serious than 6h fasting group than non-fasting group;the anxiety score of 24h fasting group is higher than the other two(F=6.509,P<0.05), and the value of the next morning fasting blood glucose in fasting group 24h is higher than other two(F=6.642,P<0.050). comparing the score of anxiety in 6h fasting group and non-fasting group, there was not significant difference, and comparing the post-embolism adverse reaction, 72 h blood amylase of all three groups and these groups one to one, there was also not significant difference ( P>0.05). Conclusion Fasting will cause and intensify the sense of hunger, anxiety and nutrition disorder of patients with hemoptysis of pulmonary tuberculosis after embolism.
3.Inhibitory Effect of Baihu Decoction on Adverse Reaction Induced by Photodynamic Therapy in Malignant Tumor Patients
Chuang CHEN ; Wei CHEN ; Zuojun ZHANG ; Zhiqiang TAN ; Hanzhong LI ; Zhifen HUANG ; Zhuozheng HUANG
Journal of Guangzhou University of Traditional Chinese Medicine 1999;0(02):-
[Objective] To observe the inhibitory effect of Baihu Decoction (BD) on adverse reaction induced by photodynamic therapy (PT) in malignant tumor patients. [Methods] Fifty-six malignant tumor patients receiving PT were equally randomized into group A and group B. The two groups received routine symptomatic western medicine treatment, and anti-inflammation treatment. Group A was treated with BD additionally. [Results] Incidence of fever was 28.6% and that of pain was 85.7% in group A, and 57.1% and 100% in group B respectively (P 0.05). Duration of fever, pain and edema was respectively 2.73?0.58, 6.71?0.81 and 5.25?0.94 days in group A, and respectively 4.56?0.76, 9.12?1.14 and 8.84?1.01 days in group B (P 0.05). In group A, there were 11 patients with white blood cell (WBC) count over 10?109/L, and the average WBC count was (10.6?2.36)?109/L; there were 18 patients with WBC count over 10?109/L, and the average WBC count was (14.3?3.17)?109/L. The difference of WBC count was significant between groups A and B (P
4.Caudate lobe as the sole remnant liver following anatomical hepatectomy for the treatment of hepatolithiasis
Chuang PENG ; Jia LI ; Weimin YI ; Zhaoxia TAN ; Bo JIANG ; Jinshu WU
Chinese Journal of Digestive Surgery 2016;15(1):81-84
Objective To investigate the safety and short-term effect of anatomical hepatectomy for the treatment of hepatolithiasis with the caudate lobe as the sole remnant liver.Methods The clinical data of 1 patient with hepatolithiasis combined with liver atrophy-hypertrophy syndrome who was admitted to the Hunan Provincial People's Hospital in April 2014 were retrospectively analyzed.The stones were located in the left and right liver, the involved liver became fibroatrophy, and the hepatic caudate lobe not containing stones became hypertrophy.The body surface area of the patient was 1.65 m2 , standard total liver volume was 1 167.63 mL.According to the result of CT, expected residual liver volume after hepatectomy was 706.12 mL, and the ratio of residual liver volume over the standard total liver was 60.47%.The radio of residual liver volume over the body mass index was 1.21%.The patient received the second exploration of common bile ducts, hepatectomy with the caudate lobe as the sole remnant liver and T tube drainage.The follow-up including recurrence of calculus was performed by outpatient examination and telephone interview up to April 2015.Results The patient underwent caudate lobe as the sole remnant liver following anatomical hepatectomy successfully without blood transfusion.The operation time and volume of intraoperative blood loss were 380 minutes and 350 mL.The peritoneal drainage tube was removed at postoperative day 2 and the patient was discharged at postoperative day 8 with a good recovery of liver function.The postoperative pathological examination showed that there were focal biliary epithelial papillary hyperplasia combined with light-medium atypical hyperplasia and no canceration.The T tube cholangiography two month later showed that there were unobstructed lower bile duct and no residual intra-and extra-hepatic stones.The liver function was normal.Then T tube was removed and patient resumed normal life.During the 1-year follow-up, no chills and fever, jaundice and abdominal pain occurred, no calculus was detected by B-ultrasonography, and computed tomography reexamination showed that remnant liver volume was increased and no intra-and extra-hepatic bile duct stones were detected.Conclusion Anatomical hepatectomy for the treatment of hepatolithiasis with the caudate lobe as the sole remnant liver is safe and feasible, with a good curative effect.
5.Laparoscopic anatomical liver resection of segment 8: a feasibility study on 9 patients
Zhiguo TAN ; Chuang PENG ; Ou LI ; Chao GUO ; Xianbo SHEN ; Zongpeng SUN ; Weimin YI ; Bo JIANG
Chinese Journal of Hepatobiliary Surgery 2021;27(3):185-187
Objective:To study the feasibility, safety and technique for laparoscopic anatomical liver resection of segment 8.Methods:The clinical data of 9 patients who underwent laparoscopic anatomical liver resection of segment 8 from January 2015 to December 2019 at Hunan Provincial People's Hospital were retrospectively analyzed. There were 6 males and 3 females, with age ranging from 29 to 67 years (average 53.6 years). The operation time, intraoperative blood loss , postoperative hospital stay, postoperative complications, and long-term survival and recurrence rates on follow-up were analysed.Results:Laparoscopic anatomical liver resection of segment 8 was successfully carried out in these patients. The mean operative time was 188.9 min(range 140-240 min). The mean estimated intraoperative blood loss was 117.8 ml (range 20-300 ml). The postoperative hospital stay was 6.9 days (range 3-12 days). One patient developed pleural effusion after operation and responded to conservative treatment. Another patients developed ascites with delayed extubation. The patient was successfully treated with conservative treatment. No patients developed complications above Clavien Dindo Ⅲa. There were no perioperative deaths. The postoperative pathological results showed hepatocellular adenoma ( n=2), hepatocellular carcinoma ( n=4), cholangiocarcinoma ( n=1), and metastatic liver cancer ( n=2). On follow-up for 12-58 months (median 22 months) one patient with hepatocellular carcinoma developed recurrence at 18 months after operation and was treated with microwave ablation. The other patients were well on follow-up. Conclusions:With adequate preoperative evaluation, reasonable case selection, rigorous surgical planning, and skilled laparoscopic techniques, laparoscopic anatomical liver resection of segment 8 was safe and feasible, and the short-term efficacy was good in this study.
7.Surgical versus non-surgical treatment of advanced intrahepatic cholangiocarcinoma: A comparative study
Jinlong GONG ; Chuang PENG ; Zheng TAN ; Wenjia YUAN ; Xiang HE ; Bo JIANG ; Jinshu WU
Chinese Journal of Hepatobiliary Surgery 2018;24(10):676-680
Objective To compare the survival outcomes between operative versus non-operative treatment of advanced intrahepatic cholangiocarcinoma.Methods This is a retrospective study.The data from 122 patients with intrahepatic cholangiocarcinoma treated at the Hunan People's Hospital,the Hepatobiliary Hospital and the Oncology Department from January 2012 to October 2017 were retrospective studied.87 patients who underwent radical surgery (anatomical hepatectomy + regional lymph node dissection) formed the operation group;35 patients who were treated with chemotherapy and/or radiotherapy and/or biological targeted therapy formed the non-operative group.The general characteristics of the two groups including age,sex,ALT,AST,CA19-9,liver function,Child's classification,AJCC staging,tumor number,vascular (hepatic artery,portal vein) invasion and regional lymph node metastasis rates were compared.The overall survival of the two groups was compared.Results There were no significant differences in age,sex,ALT,AST,CA19-9,liver function,Child's classification,AJCC staging,tumor number,vascular (hepatic artery,portal vein) invasion and regional lymph node metastasis rates (P>0.05).The overall survival of the operation group was significantly longer than that of the non-operative group (P<0.05).The mean overall survival for the 2 groups of patients were 32 months and 15 months respectively.The 1-year survival rates were 74.8% and 58.7%,and the 3 year survival rates were 42.4% and 6.5%,respectively.The 5 years survival rates were 12.3% and 0,respectively.Conclusion Operative treatment resulted in better median survival,as well as 1-,3-and 5-year survival rates than non-operative treatment for patients with advanced intrahepatic cholangiocarcinoma.
8.Surgical treatment of double outlet ventricle: report on 72 cases.
Jin-fu YANG ; Dong-xu HU ; Jian-guo HU ; Bang-liang YIN ; Xin-min ZHOU ; Wen-wu ZHOU ; Si-chuang TAN ; Ni YIN
Chinese Medical Journal 2005;118(4):344-347
9.Diagnosis and treatment of intrahepatic stone complicated with atrophy-hypertrophy complex
Jinshu WU ; Chuang PENG ; Zheng TAN ; Weimin YI
Chinese Journal of General Surgery 2017;32(10):839-842
Objective To explore the typing and surgical methods on intrahepatic stone complicated with atrophy-hypertrophy complex.Methods The clinical data of 32 cases of intrahepatic stone complicated with atrophy-hypertrophy complex from January 2014 to December 2015 in Hunan Province Peopole's Hospital were retrospectively analysed.Results These 32 cases of atrophy-hypertrophy complex accounted for 1.9% of admitted hepatolith patients.We divided the intrahepatic stone complicated with atrophy-hypertrophy syndrome into 5 types,and type-Ⅱ the most common.We performed operation combined with fiber choledochoscope to examine,smash and remove the stone.This methods could reduce the rate of residual stone to 6%.The liver will be partly atrophy with stones inside it,and the residual liver will become hypertrophy.Stones of intrahepatic bile duct lead to the change of the position of porta hepatis and straitness of primary bile duct,and the bile cannot smooth out.there will be lithogenesis and relapsing cholangitis.Patients were treated by intrahepatic biliary double-opening drainage,and followed-up for 12-36 months.There were no death cases,and the total effective rate was 94%.Conclusions Intrahepatic stones complicated with atrophy-hypertrophy complex could be diagnosed by CT scan.Selecting proper operation method to treat atrophy-hypertrophy complex may decrease residual stones and improve the quality of life.
10.Optimization of chromosome flaking technique for mesenchymal stem cells.
Maosheng CHEN ; Chuang LI ; Dehua CHENG ; Yueqiu TAN ; Hua MEI ; Siqi WANG ; Xiang LI ; Lamei CHENG
Chinese Journal of Medical Genetics 2019;36(2):143-146
OBJECTIVE:
To optimize the condition for chromosome flaking of mesenchymal stem cells to ensure the cytogenetic quality control of expanding production and clinical application.
METHODS:
Chromosomal flaking methods were optimized from current chromosome preparation techniques from the aspects of MSCs cell culture concentration, colchicine treatment time and low permeability time.
RESULTS:
By repeated pre-experiments, the optimal MSCS chromosome flaking condition of MSCs was determined as cell culture concentration of (1-2)× 10 cells per T25 cell culture bottle, and the colchicines processing time was determined as 2 hours and 10 minutes, and the low permeability was 1 hour.
CONCLUSION
The optimized chromosome flaking condition can fulfill the requirement of cytogenetic quality control for MSCs.
Cell Culture Techniques
;
Cell Differentiation
;
Cells, Cultured
;
Chromosome Disorders
;
Chromosomes, Human
;
Cytogenetics
;
Humans
;
Mesenchymal Stem Cells